Harrington Discovery Institute accelerates promising discoveries into medicines for unmet needs focusing on Major Diseases, Brain Health Medicines, COVID-19, and Rare Diseases. Our work endeavors to improve human health and better our world. We are driven by passion, innovation, and integrity, to cure diseases together.
Join NAMSA for this webinar as we walk through the key differences between EU’s In Vitro Diagnostic Directive (IVDD) and IVDR and the clinical study requirements outlined within these regulations. We will also examine ISO 20916:2019 as the Good Clinical Practice (GCP) guidance for IVD clinical performance.
Most start-up founders and investors agree that stock plans are an important tool to build great teams and retain talent. However, implementing an employee stock plan can be expensive, time-consuming, and confusing. Many founders delay using employee stocks or don't implement plans properly, which can result in team confusion instead of engagement. Join Taft partner Matt Secrist, Cake Equity co-founder Jason Atkins, and Lazurite president and general counsel Leah Brownlee for this webinar as they discuss how to get the most out of employee stock plans.
Join G2G for insights into preparing for and maximizing participation in the MHSRS conference, plus tips on navigating and engaging effectively with the Defense Health Agency, Futures Command, USAMRDC, WRAIR, USAISR and other potential collaborators within government.
Grab your favorite drink (or just a drink), come learn and interact with industry experts while they discuss hot topics in Medtech. Speaker: Dr. Wessels founded LiquidSMARTS℠. He leads the global practice and is a member of the leadership team. He is passionate and dedicated to the improvement of human performance and ethical business practices in sales and marketing. His expertise comes from more than 25 years in the healthcare industry, including 14 years as a consultant to global and local marketing and sales teams. His clients gain rapid performance improvement through analysis, design, implementation of market approach, and commercial operations execution. He leads the field in providing micro-learning for business professionals. His micro-learning approach teaches people essential soft-skills and influencing and leadership behaviors in a few minutes per day.
Join NAMSA for this webinar as we walk through an overview and understanding of the ISO 14155 standard changes, discuss how this compares to the previous 2011 version and explore why adoption, planning and implementation are key to commercial success.
Join NAMSA and the U.S. Food and Drug Administration (FDA) as we present this upcoming webinar on July 20, 2022, regarding the Accreditation Scheme for Conformity Assessment (ASCA) Pilot Program, a first-of-its-kind conformity assessment program created by the U.S. FDA. During this webinar, the FDA will highlight how the ASCA Pilot Program streamlines aspects of conformity assessments for medical device submissions, as well as what manufacturers can expect when they submit ASCA test results to the government agency.
Join us on July 28 for the inaugural Ohio HealthTech Summit brought to you by OhioX and University Hospitals Ventures. This virtual event will take a deep look at the latest technology trends and activities happening in Ohio’s rich healthcare innovation ecosystem. Topics range from digital and virtual health to emerging technologies like extended reality, AI, and blockchain. Learn how Ohio providers, corporations, entrepreneurs, and investors are partnering to deliver outstanding care to Ohio consumers and communities.
In healthcare, we often hear the phrase “patient focus” which is designed to make decisions with the patient’s safety in mind. But all too often we forget that within the workplace, we also need to consider the safety and well-being of our sterile processing professionals who are facing the risks and doing the real work. This presentation will focus on the dangers and risks we face on a daily basis in our departments as well as provide solutions for those dangers and risks.
The U.S. healthcare market is in a continuous state of flux and uncertainty. Now more than ever, it’s imperative that pharmaceutical manufacturers partner with emerging vendors to overcome the unique market access challenges of rare disease and gene/cell therapies to avoid pitfalls and to drive a successful product launch. During this webinar, our experts will provide in-depth insights on commercialization strategy, distribution models and demonstrating therapeutic value of Rare Disease & Gene/Cell therapies for patients, payers, and providers. This event features member Michael Baldzicki, Chief Brand Officer, AscellaHealth.